Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEURRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.7 | -4.8 | 11.6 | 4.3 | |
+/-Cat | - | 1.4 | 3.5 | 0.0 | -0.1 | |
+/-B’mrk | - | -0.9 | -0.2 | -1.6 | -1.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 15/05/2024 | GBX 746.00 | |
Day Change | -0.11% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 206 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BKSBGT50 | |
Fund Size (Mil) 15/05/2024 | EUR 99.00 | |
Share Class Size (Mil) 15/05/2024 | EUR 99.00 | |
Ongoing Charge 03/04/2024 | 0.25% |
Investment Objective: Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR |
The Sub-Fund aims to achieve long-term capital growth from a portfolio primarily made up of equity securities of companies in Europe. The Sub-Fund aims to achieve its investment objective by actively investing in a portfolio primarily made up of equity securities of companies domiciled, or exercising the predominant part of their economic activity, in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Hiten Savani 18/05/2020 | ||
Daniel Swift 18/05/2020 | ||
Inception Date 18/05/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR | 15/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.03 |
ASML Holding NV | Technology | 3.47 |
AstraZeneca PLC | Healthcare | 2.87 |
Shell PLC | Energy | 2.54 |
SAP SE | Technology | 2.44 |
Increase Decrease New since last portfolio | ||
Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR |